Ernexa Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $13.65 million. The enterprise value is $9.93 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ERNA has 7.67 million shares outstanding. The number of shares has increased by 704.66% in one year.
| Current Share Class | 7.67M |
| Shares Outstanding | 7.67M |
| Shares Change (YoY) | +704.66% |
| Shares Change (QoQ) | +45.58% |
| Owned by Insiders (%) | 53.44% |
| Owned by Institutions (%) | 1.78% |
| Float | 3.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.59 |
| Forward PS | n/a |
| PB Ratio | 3.00 |
| P/TBV Ratio | 5.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.81 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.19% |
| Return on Invested Capital (ROIC) | -32.16% |
| Return on Capital Employed (ROCE) | -238.46% |
| Revenue Per Employee | $81,333 |
| Profits Per Employee | -$7.29M |
| Employee Count | 6 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ERNA has paid $34,000 in taxes.
| Income Tax | 34,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.21% in the last 52 weeks. The beta is 6.64, so ERNA's price volatility has been higher than the market average.
| Beta (5Y) | 6.64 |
| 52-Week Price Change | -89.21% |
| 50-Day Moving Average | 1.29 |
| 200-Day Moving Average | 2.81 |
| Relative Strength Index (RSI) | 72.07 |
| Average Volume (20 Days) | 10,919,346 |
Short Selling Information
The latest short interest is 39,599, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 39,599 |
| Short Previous Month | 55,470 |
| Short % of Shares Out | 0.52% |
| Short % of Float | 1.25% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, ERNA had revenue of $488,000 and -$43.72 million in losses. Loss per share was -$15.05.
| Revenue | 488,000 |
| Gross Profit | 548,000 |
| Operating Income | -11.76M |
| Pretax Income | -43.67M |
| Net Income | -43.72M |
| EBITDA | -11.67M |
| EBIT | -11.76M |
| Loss Per Share | -$15.05 |
Full Income StatementBalance Sheet
The company has $4.32 million in cash and $593,000 in debt, giving a net cash position of $3.72 million or $0.49 per share.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 593,000 |
| Net Cash | 3.72M |
| Net Cash Per Share | $0.49 |
| Equity (Book Value) | 4.44M |
| Book Value Per Share | 0.59 |
| Working Capital | 2.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.43 million and capital expenditures -$19,000, giving a free cash flow of -$14.45 million.
| Operating Cash Flow | -14.43M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -14.45M |
| FCF Per Share | -$1.88 |
Full Cash Flow StatementMargins
| Gross Margin | 112.30% |
| Operating Margin | -2,410.45% |
| Pretax Margin | -8,948.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ERNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -704.66% |
| Shareholder Yield | -704.66% |
| Earnings Yield | -320.19% |
| FCF Yield | -105.80% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 12, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
ERNA has an Altman Z-Score of -46.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.65 |
| Piotroski F-Score | 4 |
